Rainer Ehling

Rainer Ehling

UNVERIFIED PROFILE

Are you Rainer Ehling?   Register this Author

Register author
Rainer Ehling

Rainer Ehling

Publications by authors named "Rainer Ehling"

Are you Rainer Ehling?   Register this Author

36Publications

808Reads

42Profile Views

Levodopa-responsive dystonia and parkinsonism in Fahr syndrome.

Neurol Clin Pract 2019 Dec;9(6):527-529

Department of Neurology (MR), Clinic for Rehabilitation Münster; Department of Internal Medicine (WH) and Department of Neurology (MK), Hochzirl Hospital, Zirl; and Department of Neurology (RE, CB), Clinic for Rehabilitation Münster, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/CPJ.0000000000000663DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927444PMC
December 2019

Responsiveness and meaningful improvement of mobility measures following MS rehabilitation.

Neurology 2018 11 17;91(20):e1880-e1892. Epub 2018 Oct 17.

From the REVAL Rehabilitation Research Center (I.B., P.F.), BIOMED Biomedical Research Institute, Faculty of Medicine & Life Sciences, Hasselt University, Belgium; Haukeland University Hospital (Norwegian MS Competence Centre and Department of Physiotherapy) (T.S.), Bergen, Norway; Department of Physical Therapy (A.K.), Sackler Faculty of Medicine, Tel-Aviv University; Multiple Sclerosis Center (A.K.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Rehabilitation, Third Faculty of Medicine (K.R.), Charles University and Faculty Hospital Royal Vineyards, Prague, Czech Republic; Multiple Sclerosis Center (A.H.-M.), Hakadal AS, Norway; Department of Neurology (R.E.), Clinic for Rehabilitation Münster, Austria; Eugenia Epalza Rehabilitation Center (I.E.M.), Bilbao, Spain; Clinical Center in Belgrado (U.N.), Serbia; Italian Multiple Sclerosis Foundation (FISM) (A.T.), Scientific Research Area, Genoa, Italy; National MS Center (P.H.), Melsbroek; AZ Klina (G.A.), Campus De Mick, Rehabilitation, Brasschaat, Belgium; John Paul II Rehabilitation Centre for People with Multiple Sclerosis (G.S.), Borne Sulinowo, Poland; Neurological Rehabilitation Centre Quellenhof (K.G.), Sana AG, Germany; IRCSS Fondazione Don Carlo Gnocchi (D.C.), Milan, Italy; Rehabilitation and MS Center Overpelt (S.B.), Belgium; University of Colorado-Anschutz Medical Campus (J.H.); and Section of Sport Science (U.D.), Department Public Health, Aarhus University, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000006532DOI Listing
November 2018

Successful long-term management of spasticity in patients with multiple sclerosis using a software application (APP): A pilot study.

Mult Scler Relat Disord 2017 Oct 27;17:15-21. Epub 2017 Jun 27.

Department of Neurology, Clinic for Rehabilitation Münster, Münster, Austria; Karl Landsteiner Institute for interdisciplinary research at the Clinic for Rehabilitation Münster, Münster, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2017.06.013DOI Listing
October 2017

Discontinuation of disease-modifying therapies in multiple sclerosis - Clinical outcome and prognostic factors.

Mult Scler 2017 Aug 20;23(9):1241-1248. Epub 2016 Oct 20.

Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458516675751DOI Listing
August 2017

Continuous intra-arterial nimodipine infusion in refractory symptomatic vasospasm after subarachnoid hemorrhage.

Springerplus 2016 18;5(1):1807. Epub 2016 Oct 18.

Department of Neurology, Neurological Intensive Care Unit, Medical University of Innsbruck , Anichstrasse 35, 6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40064-016-3495-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069241PMC
October 2016

Rethinking the importance of paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis: They do matter.

Mult Scler Relat Disord 2016 Sep 27;9:150-4. Epub 2016 Jul 27.

Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2016.07.014DOI Listing
September 2016

Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: A prospective observational clinical trial.

J Neuroimmunol 2015 Oct 10;287:98-105. Epub 2015 Aug 10.

Clinical Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria; Clinics for Neurological Rehabilitation Münster, Groeben 700, 6232 Münster, Austria; Department of Radiology, Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2015.08.004DOI Listing
October 2015

Persistency of neutralizing antibodies depends on titer and interferon-beta preparation.

Mult Scler 2012 May 19;18(5):610-5. Epub 2011 Oct 19.

Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458511426738DOI Listing
May 2012

Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases.

Clin Immunol 2011 Mar 18;138(3):247-54. Epub 2010 Dec 18.

Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clim.2010.11.013DOI Listing
March 2011

Selective amygdalo-hippocampectomy as a potential trigger for disease progression in multiple sclerosis.

Clin Neurol Neurosurg 2011 Feb 18;113(2):136-8. Epub 2010 Dec 18.

Clinical Department of Neurology, Innsbruck Medical University, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clineuro.2010.08.004DOI Listing
February 2011

Natalizumab treatment reduces endothelial activity in MS patients.

J Neuroimmunol 2010 Oct 23;227(1-2):190-4. Epub 2010 Aug 23.

Department of Neurology, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2010.07.012DOI Listing
October 2010

Multiple sclerosis - established and novel therapeutic approaches.

Cent Nerv Syst Agents Med Chem 2010 Mar;10(1):3-15

Clinical Department of Neurology, Innsbruck Medical University, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/187152410790780127DOI Listing
March 2010

Features of intrathecal immunoglobulins in patients with multiple sclerosis.

J Neurol Sci 2010 Jan 13;288(1-2):147-50. Epub 2009 Oct 13.

Clinical Department of Neurology, Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2009.09.016DOI Listing
January 2010

Intrathecal anti-alphaB-crystallin IgG antibody responses: potential inflammatory markers in Guillain-Barré syndrome.

J Neurol 2008 Jun 11;255(6):917-24. Epub 2008 Jul 11.

Clinical Department of Neurology, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-008-0815-9DOI Listing
June 2008

Increased serum levels of soluble CD14 indicate stable multiple sclerosis.

J Neuroimmunol 2006 Dec 13;181(1-2):145-9. Epub 2006 Oct 13.

Clinical Department of Neurology, Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2006.09.002DOI Listing
December 2006

Epitope specificity of neutralizing antibodies against IFN-beta.

J Interferon Cytokine Res 2004 May;24(5):283-90

Department of Neurology, University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://www.liebertpub.com/doi/10.1089/107999004323065066
Publisher Site
http://dx.doi.org/10.1089/107999004323065066DOI Listing
May 2004